Develop and optimize antagonists assays in ACVR1-WT, ACVR1-R206H, ACVR1-T283I and ACVR1-R206H-T283I cells

Ended Purchase Order Awarded

Contract number
75N95C25P00106
Awardee
Awarding agency
Obligated
$13,200

Award facts

Contract value 100% obligated
$13,200.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
North Bethesda, MD 20852, USA

Award details come from SAM.gov/FPDS.

About this award

This is a $13,200 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Dexorgen Inc., doing business as Codex Biosolutions Inc. The contract is for the development and optimization of antagonist assays in cells expressing different variants of the ACVR1 gene. Codex Biosolutions is a minority-owned small disadvantaged business located in Gaithersburg, Maryland that specializes in advanced biotechnology research and services, particularly related to cell line development, genetic engineering, and translational science support for federal agencies. This contract does not have a set-aside designation.

Quick answers

Who was awarded contract 75N95C25P00106?

75N95C25P00106 was awarded to Dexorgen Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on September 18, 2025.

How much is contract 75N95C25P00106 worth?

The government has obligated $13,200 on 75N95C25P00106.

Was contract 75N95C25P00106 competed?

The extent of competition for 75N95C25P00106 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award